Andrew J. Greenfield
2021
In 2021, Andrew J. Greenfield earned a total compensation of $4M as Executive Vice President and Chief Commercial Officer at ABIOMED, a 43% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $328,095 |
|---|---|
| Option Awards | $377,276 |
| Salary | $301,454 |
| Stock Awards | $3,010,116 |
| Other | $9,126 |
| Total | $4,026,067 |
Greenfield received $3M in stock awards, accounting for 75% of the total pay in 2021.
Greenfield also received $328.1K in non-equity incentive plan, $377.3K in option awards, $301.5K in salary and $9.1K in other compensation.
Rankings
In 2021, Andrew J. Greenfield's compensation ranked 3,330th out of 12,404 executives tracked by ExecPay. In other words, Greenfield earned more than 73.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,330 out of 12,404 | 73rd |
Division Manufacturing | 1,354 out of 5,494 | 75th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 164 out of 798 | 79th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 107 out of 519 | 79th |
Industry Surgical and Medical Instruments and Apparatus | 71 out of 324 | 78th |
Source: SEC filing on June 28, 2022.
Greenfield's colleagues
We found four more compensation records of executives who worked with Andrew J. Greenfield at ABIOMED in 2021.